165 related articles for article (PubMed ID: 7696263)
21. Altering the mouth of a hydrophobic pocket. Structure and kinetics of human carbonic anhydrase II mutants at residue Val-121.
Nair SK; Calderone TL; Christianson DW; Fierke CA
J Biol Chem; 1991 Sep; 266(26):17320-5. PubMed ID: 1910042
[TBL] [Abstract][Full Text] [Related]
22. Kinetic and spectroscopic studies of hydrophilic amino acid substitutions in the hydrophobic pocket of human carbonic anhydrase II.
Krebs JF; Rana F; Dluhy RA; Fierke CA
Biochemistry; 1993 May; 32(17):4496-505. PubMed ID: 8485128
[TBL] [Abstract][Full Text] [Related]
23. Catalytic and inhibitor-binding properties of some active-site mutants of human carbonic anhydrase I.
Engstrand C; Jonsson BH; Lindskog S
Eur J Biochem; 1995 May; 229(3):696-702. PubMed ID: 7758465
[TBL] [Abstract][Full Text] [Related]
24. Probing the energetics of dissociation of carbonic anhydrase-ligand complexes in the gas phase.
Gao J; Wu Q; Carbeck J; Lei QP; Smith RD; Whitesides GM
Biophys J; 1999 Jun; 76(6):3253-60. PubMed ID: 10354450
[TBL] [Abstract][Full Text] [Related]
25. Structure determination of murine mitochondrial carbonic anhydrase V at 2.45-A resolution: implications for catalytic proton transfer and inhibitor design.
Boriack-Sjodin PA; Heck RW; Laipis PJ; Silverman DN; Christianson DW
Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10949-53. PubMed ID: 7479916
[TBL] [Abstract][Full Text] [Related]
26. Importance of the conserved active-site residues Tyr7, Glu106 and Thr199 for the catalytic function of human carbonic anhydrase II.
Liang Z; Xue Y; Behravan G; Jonsson BH; Lindskog S
Eur J Biochem; 1993 Feb; 211(3):821-7. PubMed ID: 8436138
[TBL] [Abstract][Full Text] [Related]
27. Localization of carbonic anhydrase in living osteoclasts with bodipy 558/568-modified acetazolamide, a thiadiazole carbonic anhydrase inhibitor.
Brubaker KD; Mao F; Gay CV
J Histochem Cytochem; 1999 Apr; 47(4):545-50. PubMed ID: 10082756
[TBL] [Abstract][Full Text] [Related]
28. Structure of an engineered His3Cys zinc binding site in human carbonic anhydrase II.
Ippolito JA; Christianson DW
Biochemistry; 1993 Sep; 32(38):9901-5. PubMed ID: 8399159
[TBL] [Abstract][Full Text] [Related]
29. Disruption of the active site solvent network in carbonic anhydrase II decreases the efficiency of proton transfer.
Jackman JE; Merz KM; Fierke CA
Biochemistry; 1996 Dec; 35(51):16421-8. PubMed ID: 8987973
[TBL] [Abstract][Full Text] [Related]
30. Structural aspects of isozyme selectivity in the binding of inhibitors to carbonic anhydrases II and IV.
Kim CY; Whittington DA; Chang JS; Liao J; May JA; Christianson DW
J Med Chem; 2002 Feb; 45(4):888-93. PubMed ID: 11831900
[TBL] [Abstract][Full Text] [Related]
31. Effect of incorporating a thiophene tail in the scaffold of acetazolamide on the inhibition of human carbonic anhydrase isoforms I, II, IX and XII.
Biswas S; McKenna R; Supuran CT
Bioorg Med Chem Lett; 2013 Oct; 23(20):5646-9. PubMed ID: 23993330
[TBL] [Abstract][Full Text] [Related]
32. Functional consequences of engineering the hydrophobic pocket of carbonic anhydrase II.
Fierke CA; Calderone TL; Krebs JF
Biochemistry; 1991 Nov; 30(46):11054-63. PubMed ID: 1657158
[TBL] [Abstract][Full Text] [Related]
33. Drug-protein interactions. Refined structures of three sulfonamide drug complexes of human carbonic anhydrase I enzyme.
Chakravarty S; Kannan KK
J Mol Biol; 1994 Oct; 243(2):298-309. PubMed ID: 7932756
[TBL] [Abstract][Full Text] [Related]
34. Catalytic enhancement of human carbonic anhydrase III by replacement of phenylalanine-198 with leucine.
LoGrasso PV; Tu CK; Jewell DA; Wynns GC; Laipis PJ; Silverman DN
Biochemistry; 1991 Aug; 30(34):8463-70. PubMed ID: 1909176
[TBL] [Abstract][Full Text] [Related]
35. Free-solution interaction assay of carbonic anhydrase to its inhibitors using back-scattering interferometry.
Morcos EF; Kussrow A; Enders C; Bornhop D
Electrophoresis; 2010 Nov; 31(22):3691-5. PubMed ID: 20972990
[TBL] [Abstract][Full Text] [Related]
36. Proton transfer by histidine 67 in site-directed mutants of human carbonic anhydrase III.
Ren X; Tu C; Laipis PJ; Silverman DN
Biochemistry; 1995 Jul; 34(26):8492-8. PubMed ID: 7599138
[TBL] [Abstract][Full Text] [Related]
37. Localization of the Cl-/HCO3- anion exchanger binding site to the amino-terminal region of carbonic anhydrase II.
Vince JW; Carlsson U; Reithmeier RA
Biochemistry; 2000 Nov; 39(44):13344-9. PubMed ID: 11063570
[TBL] [Abstract][Full Text] [Related]
38. Selection of carbonic anhydrase variants displayed on phage. Aromatic residues in zinc binding site enhance metal affinity and equilibration kinetics.
Hunt JA; Fierke CA
J Biol Chem; 1997 Aug; 272(33):20364-72. PubMed ID: 9252341
[TBL] [Abstract][Full Text] [Related]
39. Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib.
Di Fiore A; Pedone C; D'Ambrosio K; Scozzafava A; De Simone G; Supuran CT
Bioorg Med Chem Lett; 2006 Jan; 16(2):437-42. PubMed ID: 16290146
[TBL] [Abstract][Full Text] [Related]
40. Structural study of interaction between brinzolamide and dorzolamide inhibition of human carbonic anhydrases.
Pinard MA; Boone CD; Rife BD; Supuran CT; McKenna R
Bioorg Med Chem; 2013 Nov; 21(22):7210-5. PubMed ID: 24090602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
